QuestionsQuestions (PRC Resolution NO. 174, S. 1990)
The main purpose is to provide guidelines on the implementation of the Drug Test Operations Management Information System (DTOMIS) to regulate drug testing laboratories and ensure accuracy, reliability, and efficiency in drug testing results in accordance with Republic Act No. 9165.
The Department of Health (DOH) is responsible for licensing, accrediting, and monitoring Drug Test Laboratories/Centers under the provisions of Republic Act No. 9165.
Republic Act No. 9165, known as the Comprehensive Dangerous Drugs Act of 2002, mandates the regulation of Drug Test Laboratories/Centers.
Effective October 3, 2003, the DOH ordered the deployment of DTOMIS software to all DOH trained personnel and accredited Drug Test Laboratories/Centers.
Objectives include providing interconnectivity and standardized solutions for accredited DTLs/DTCs, efficient data management, enforcement of standards, producing accurate and timely drug test data, improving client satisfaction, strengthening quality assurance, and generating significant cost savings.
Only drug test results generated by the DTOMIS shall be accepted as official by the DOH and all Agency Data Beneficiaries starting November 3, 2003.
Agency Data Beneficiaries are government agencies that are members of the Dangerous Drugs Board and other entities as determined by the DOH and the Dangerous Drugs Board.
Agency Data Beneficiaries must request the Security Codes from the DOH, protect their confidentiality, identify authorized personnel who are sworn to maintain secrecy, and understand the implications and sanctions for breaching confidentiality.
Any previous issuances that are contrary or inconsistent with the provisions of this Order are rescinded or modified accordingly.
The separability clause states that if any provision or its application is held invalid, the rest of the guidelines remain unaffected and continue to be in force.